William D. Turner - 05 Jan 2024 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
Chief Development Officer
Signature
/s/ Joseph R. Young, Attorney-in-Fact
Issuer symbol
VERA
Transactions as of
05 Jan 2024
Net transactions value
$0
Form type
4
Filing time
09 Jan 2024, 16:05:39 UTC
Previous filing
01 Jul 2022
Next filing
20 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERA Stock Option (right to buy) Award $0 +275,000 $0.000000 275,000 05 Jan 2024 Class A Common Stock 275,000 $15.53 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the shares subject to the option vest on January 5, 2025, and 1/48 of the shares vest monthly thereafter, subject to continuous service of the Reporting Person through each vesting date.